WuXi Healthcare Ventures Overview
- Investor Type
- Venture Capital
- Status
- Inactive
- Investments
- 60
- Portfolio
- 22
- Exits
- 20
WuXi Healthcare Ventures General Information
Description
WuXi Healthcare Ventures was a corporate venture arm of WuXi PharmaTech and was based in Cambridge, Massachusetts with an additional office in Shanghai, China. The firm used to invest in life science, therapeutic, platform technology, and diagnostic companies, with an emphasis on China and the United States. On May 2017, the firm merged with Frontline BioVentures to form a new firm called 6 Dimensions Capital.
Contact Information
Website
www.wuxiventures.com
Investor Status
Acquired/Merged
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 55 Cambridge Parkway
- 8th Floor
- Cambridge, MA 02142
- United States
WuXi Healthcare Ventures Investments (60)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| XW Laboratories | 17-Sep-2020 | Later Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 000000000 | 28-Nov-2019 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
| 00000 000000000000 | 22-Feb-2019 | 00000 00000 | 00.000 | Drug Discovery | Startup | |
| 000000 00000000000 | 09-May-2018 | 00000 00000 | 00000 | Biotechnology | Generating Revenue/Not Profitable | 0000 000 00.0 |
| 000000 0000000 | 02-May-2018 | 00000 00000 | 0000 | Biotechnology | Startup | |
| 000 00000000 | 26-Mar-2018 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 3 | 00 00 00.0 |
| 000000 00000000000 | 15-Mar-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00 00.0 |
| 00000000 | 02-Jan-2018 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | 00 00 00.0 |
| Medeor Therapeutics | 27-Nov-2017 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | 000 00 00.0 |
| XW Laboratories | 20-Sep-2017 | Early Stage VC | 000.00 | Drug Discovery | Pre-Clinical Trials |
WuXi Healthcare Ventures Exits (20)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Adagene | 09-Feb-2021 | IPO | 00000 |
| 00000000 | 01-May-2020 | 000 00 00000000 | |
| 000000 00000000000 | 23-May-2019 | 000 | 0000 |
| 000000 00000000000 | 26-Feb-2019 | 000 | 00000 |
| 00000 0000000000 | 31-Oct-2018 | 000 | 0000 |
| 000 00000000 | 14-Sep-2018 | 000 | 00000 |
| 0000 00000000 | 16-Aug-2018 | 000000000000000000 | |
| 00000 000000000000 | 03-May-2018 | 000 | 0000 |
| Syros Pharmaceuticals | 01-Apr-2017 | Secondary Transaction - Open Market | |
| Syros Pharmaceuticals | 15-Nov-2016 | Public Investment 2nd Offering |
WuXi Healthcare Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore WuXi Healthcare Ventures‘s full profile, request access.
Request a free trialWuXi Healthcare Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialWuXi Healthcare Ventures Co-Investors (77)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| 6 Dimensions Capital | 5 | 0 |
|
|
|
| Sequoia Capital China | 0 | 0 |
|
|
|
| ARCH Venture Partners | 0 | 0 |
|
|
|
| Canaan Partners | 0 | 0 |
|
|
|
| GV | 0 | 0 |
|
|